Stem Cell Therapy and Tissue Engineering for Cardiovascular Repair: From Basic Research to Clinical Applications
Editat de Nabil Dib, Doris A. Taylor, Edward B. Diethrichen Limba Engleză Paperback – 4 noi 2014
New breakthroughs in stem cell therapy and tissue engineering have promised to reverse this dismal outcome by cardiovascular repair. World authorities, including scientists and regulatory authorities, have joined in a collaborative effort to present for the reader the first collective review of stem cell therapy for the treatment of cardiovascular disease. These contributions in basic science, pre-clinical and clinical experience guided by the regulatory pathways, assure a rapid course of translational research and clinical trials.
The contents of this publication will become a prerequisite for those preparing to meet the challenges of this exciting and potentially rewarding field of stem cell research.
Toate formatele și edițiile | Preț | Express |
---|---|---|
Paperback (1) | 1079.03 lei 6-8 săpt. | |
Springer Us – 4 noi 2014 | 1079.03 lei 6-8 săpt. | |
Hardback (1) | 1085.85 lei 6-8 săpt. | |
Springer Us – 15 noi 2005 | 1085.85 lei 6-8 săpt. |
Preț: 1079.03 lei
Preț vechi: 1135.83 lei
-5% Nou
Puncte Express: 1619
Preț estimativ în valută:
206.60€ • 215.13$ • 171.41£
206.60€ • 215.13$ • 171.41£
Carte tipărită la comandă
Livrare economică 14-28 februarie
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9781489985644
ISBN-10: 1489985646
Pagini: 356
Ilustrații: XIX, 335 p.
Dimensiuni: 155 x 235 x 19 mm
Greutate: 0.5 kg
Ediția:2006
Editura: Springer Us
Colecția Springer
Locul publicării:New York, NY, United States
ISBN-10: 1489985646
Pagini: 356
Ilustrații: XIX, 335 p.
Dimensiuni: 155 x 235 x 19 mm
Greutate: 0.5 kg
Ediția:2006
Editura: Springer Us
Colecția Springer
Locul publicării:New York, NY, United States
Public țintă
ResearchDescriere
In excess of 7 million people worldwide die of coronary heart disease each year. Only one-third of these heart attack victims recover completely. The remainder suffer the consequences of myocardial infarction and its ill fated remodeling process, resulting in chronic congestive heart failure. This malady alone is the leading cause of hospital admissions in the United States.
New breakthroughs in stem cell therapy and tissue engineering have promised to reverse this dismal outcome by cardiovascular repair. World authorities, including scientists and regulatory authorities, have joined in a collaborative effort to present for the reader the first collective review of stem cell therapy for the treatment of cardiovascular disease. These contributions in basic science, pre-clinical and clinical experience guided by the regulatory pathways, assure a rapid course of translational research and clinical trials.
The contents of this publication will become a prerequisite for those preparing to meet the challenges of this exciting and potentially rewarding field of stem cell research.
New breakthroughs in stem cell therapy and tissue engineering have promised to reverse this dismal outcome by cardiovascular repair. World authorities, including scientists and regulatory authorities, have joined in a collaborative effort to present for the reader the first collective review of stem cell therapy for the treatment of cardiovascular disease. These contributions in basic science, pre-clinical and clinical experience guided by the regulatory pathways, assure a rapid course of translational research and clinical trials.
The contents of this publication will become a prerequisite for those preparing to meet the challenges of this exciting and potentially rewarding field of stem cell research.
Cuprins
Myocardial Remodeling.- Ventricular Remodeling In Ischemic Cardiomyopathy.- Myocardial Regeneration.- Myocardial Regeneration: Which Cell and Why.- Cardiac Stem Cells.- Cardiac Stem Cells for Myocardial Regeneration.- Skeletal Myoblast.- A Historic Recapitulation of Myoblast Transplantation.- Myoblast Cell Transplantation: Preclinical Studies.- Skeletal Myoblasts: The European Experience.- Skeletal Myoblasts: The U.S. Experience.- Progenitor Cells.- Progenitor Cells for Cardiac Regeneration.- Bone Marrow.- Bone Marrow-Derived Stem Cell for Myocardial Regeneration: Preclinical Experience.- Bone Marrow Derived Stem Cells for Myocardial Regeneration: Clinical Experience, Surgical Delivery.- Autologous Mononuclear Bone Marrow Cell Transplantion for Myocardial Infarction: The German Experience.- Autologous Mononuclear Bone Marrow Transplantation for Myocardial Infarction: The Spanish Experience.- Mobilizing Bone Marrow Stem Cells for Myocardial Repair After Acute Myocardial Infarction.- Percutaneous Stem Cell Transplantation.- Percutaneous Myoblast Transplantation: Steps In Translational Research.- A Porcine Model of Myocardial Infarction for Evaluation of Cell Transplantation.- Tissue Engineering.- Tissue Engineering for Myocardial Regeneration.- Functional and Electrophysiological Assessment after Cell Tranplantation.- The Role of Pet Scan in Stem Cell Therapy.- The Measurement of Systolic Function in the Mammalian Heart.- Electrophysiological Aspects of Cell Transplantation.- Regulatory Perspective.- Regulatory Considerations in Manufacturing, Product Testing, and Preclinical Development of Cellular Products for Cardiac Repair.
Textul de pe ultima copertă
Stem Cell Therapy & Tissue Engineering for Cardiovascular Repair
Dib, Taylor, Diethrich
Stem Cell Therapy & Tissue Engineering for Cardiovascular Repair serves as an essential reference material covering these emerging technologies in cardiovascular research. Written by prominent world authorities presenting commissioned summaries, Stem Cell Therapy & Tissue Engineering for Cardiovascular Repair discusses the spectrum of stem cell and tissue engineering from basic research to clinical applications, offering a comprehensive, integrated reference.
Key Features:
Covers the fields of translational research and clinical applications including,
- Pertinent information on cell isolation, expansion, and delivery, both in animals and humans
- Overview of embryonic, bone marrow, and myoblast cell culturing and transplantation
- Detailed explanations of the FDA regulatory pathways for cell production
- Preclinical requirements for investigational new drug applications.
- Regulatory requirements that can be applied to a variety of stem cell therapies
Stem Cell Therapy & Tissue Engineering for Cardiovascular Repair is essential for all cardiovascular research scientists, clinical researchers, and industry professionals wishing to take advantage of the latest and greatest in the continuously emerging field of stem cell therapy and tissue engineering for cardiovascular repair.
the Editors:
Nabil Dib, M.D., M.Sc, F.A.C.C, Director of Interventional Cardiology Research, Arizona Heart Institute and Heart Hospital, Phoenix, Arizona
Doris Taylor, Ph.D., Bakken Professor, Director, Center for Cardiovascular Repair, University of Minnesota, Minneapolis, Minnesota
Edward B. Diethrich, M.D., Medical Director, Arizona Heart Institute and Heart Hospital, Phoenix, Arizona.
Dib, Taylor, Diethrich
Stem Cell Therapy & Tissue Engineering for Cardiovascular Repair serves as an essential reference material covering these emerging technologies in cardiovascular research. Written by prominent world authorities presenting commissioned summaries, Stem Cell Therapy & Tissue Engineering for Cardiovascular Repair discusses the spectrum of stem cell and tissue engineering from basic research to clinical applications, offering a comprehensive, integrated reference.
Key Features:
Covers the fields of translational research and clinical applications including,
- Pertinent information on cell isolation, expansion, and delivery, both in animals and humans
- Overview of embryonic, bone marrow, and myoblast cell culturing and transplantation
- Detailed explanations of the FDA regulatory pathways for cell production
- Preclinical requirements for investigational new drug applications.
- Regulatory requirements that can be applied to a variety of stem cell therapies
Stem Cell Therapy & Tissue Engineering for Cardiovascular Repair is essential for all cardiovascular research scientists, clinical researchers, and industry professionals wishing to take advantage of the latest and greatest in the continuously emerging field of stem cell therapy and tissue engineering for cardiovascular repair.
the Editors:
Nabil Dib, M.D., M.Sc, F.A.C.C, Director of Interventional Cardiology Research, Arizona Heart Institute and Heart Hospital, Phoenix, Arizona
Doris Taylor, Ph.D., Bakken Professor, Director, Center for Cardiovascular Repair, University of Minnesota, Minneapolis, Minnesota
Edward B. Diethrich, M.D., Medical Director, Arizona Heart Institute and Heart Hospital, Phoenix, Arizona.
Caracteristici
World authorities, including scientists and regulatory authorities, have joined in a collaborative effort to present for the reader the first collective review of stem cell therapy for the treatment of cardiovascular disease
Includes supplementary material: sn.pub/extras
Includes supplementary material: sn.pub/extras